| Four months of rifampin or nine months of isoniazid for latent tuberculosis in adults D Menzies, M Adjobimey, R Ruslami, A Trajman, O Sow, H Kim, ... New England Journal of Medicine 379 (5), 440-453, 2018 | 393 | 2018 |
| Association between Gc genotype and susceptibility to TB is dependent on vitamin D status AR Martineau, ACCS Leandro, ST Anderson, SM Newton, KA Wilkinson, ... European Respiratory Journal 35 (5), 1106-1112, 2010 | 149 | 2010 |
| Preditores dos desfechos do tratamento da tuberculose RL Orofino, PEA Brasil, A Trajman, CAS Schmaltz, M Dalcolmo, VC Rolla Jornal Brasileiro de Pneumologia 38, 88-97, 2012 | 115* | 2012 |
| Chagas disease, France FX Lescure, A Canestri, H Melliez, S Jauréguiberry, M Develoux, ... Emerging infectious diseases 14 (4), 644, 2008 | 114 | 2008 |
| Frequent occult hepatitis B virus infection in patients infected with human immunodeficiency virus type 1 EA Santos, CFT Yoshida, VC Rolla, JM Mendes, IF Vieira, J Arabe, ... European Journal of Clinical Microbiology and Infectious Diseases 22, 92-98, 2003 | 107 | 2003 |
| Clinical and therapeutic features of pulmonary nontuberculous mycobacterial disease, Rio de Janeiro, Brazil KGC de Mello, FCQ Mello, L Borga, V Rolla, RS Duarte, EP Sampaio, ... Emerging infectious diseases 19 (3), 393, 2013 | 93 | 2013 |
| Systematic review of prediction models for pulmonary tuberculosis treatment outcomes in adults LS Peetluk, FM Ridolfi, PF Rebeiro, D Liu, VC Rolla, TR Sterling BMJ open 11 (3), e044687, 2021 | 67 | 2021 |
| Anemia in tuberculosis cases: A biomarker of severity? EB de Mendonca, CAS Schmaltz, FM Sant’Anna, AG Vizzoni, ... Plos one 16 (2), e0245458, 2021 | 64 | 2021 |
| Immune reconstitution syndrome in patients treated for HIV and tuberculosis in Rio de Janeiro FC Serra, D Hadad, RL Orofino, F Marinho, C Lourenço, M Morgado, ... Brazilian Journal of Infectious Diseases 11, 462-465, 2007 | 57 | 2007 |
| RePORT International: advancing tuberculosis biomarker research through global collaboration CD Hamilton, S Swaminathan, DJ Christopher, J Ellner, A Gupta, ... Clinical Infectious Diseases 61 (suppl_3), S155-S159, 2015 | 55 | 2015 |
| Factors associated with clinical and topographical features of laryngeal tuberculosis JGC Reis, CSM Reis, DCS Costa, MM Lucena, AO Schubach, ... PloS one 11 (4), e0153450, 2016 | 48 | 2016 |
| The roles of GSTM1 and GSTT1 null genotypes and other predictors in anti‐tuberculosis drug‐induced liver injury TP Monteiro, KB El‐Jaick, AL Jeovanio‐Silva, P Brasil, MJM Costa, ... Journal of clinical pharmacy and therapeutics 37 (6), 712-718, 2012 | 47 | 2012 |
| Morbidity and survival in advanced AIDS in Rio de Janeiro, Brazil AJ Gadelha, N Accacio, RLB Costa, MC Galhardo, MR Cotrim, RV Souza, ... Revista do Instituto de Medicina Tropical de São Paulo 44, 179-186, 2002 | 47 | 2002 |
| Nutritional supplementation is a necessary complement to dietary counseling among tuberculosis and tuberculosis-HIV patients AC Bacelo, A Ramalho, PE Brasil, CS Cople-Rodrigues, I Georg, E Paiva, ... PLoS One 10 (8), e0134785, 2015 | 46 | 2015 |
| Factors impacting early mortality in tuberculosis/HIV patients: differences between subjects naive to and previously started on HAART CAS Schmaltz, G Santoro-Lopes, MC Lourenço, MG Morgado, ... Public Library of Science 7 (9), e45704, 2012 | 43 | 2012 |
| High prevalence of hepatitis B virus infection among tuberculosis patients with and without HIV in Rio de Janeiro, Brazil CA Blal, SRL Passos, C Horn, I Georg, MG Bonecini-Almeida, VC Rolla, ... European Journal of Clinical Microbiology and Infectious Diseases 24, 41-43, 2005 | 40 | 2005 |
| Influence of HIV infection on mortality in a cohort of patients treated for tuberculosis in the context of wide access to HAART, in Rio de Janeiro, Brazil CAS Schmaltz, FM Sant'Anna, SC Neves, L de Souza Velasque, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 52 (5), 623-628, 2009 | 39 | 2009 |
| Safety, efficacy and pharmacokinetics of ritonavir 400mg/saquinavir 400mg twice daily plus rifampicin combined therapy in HIV patients with tuberculosis VC Rolla, MA da Silva Vieira, DP Pinto, MC Lourenço, ... Clinical Drug Investigation 26, 469-479, 2006 | 39 | 2006 |
| A phase 2 randomized trial of a rifapentine plus moxifloxacin-based regimen for treatment of pulmonary tuberculosis MB Conde, FCQ Mello, RS Duarte, SC Cavalcante, V Rolla, M Dalcolmo, ... PLoS One 11 (5), e0154778, 2016 | 38 | 2016 |
| Drug-resistant tuberculosis in six hospitals in Rio de Janeiro, Brazil RC Brito, FCQ Mello, MK Andrade, H Oliveira, W Costa, HJ Matos, ... The international journal of tuberculosis and lung disease 14 (1), 24-33, 2010 | 38 | 2010 |
